drugset / Trial / NCT02146079
A Trial to Assess the Pharmacokinetics, Pharmacodynamics, and the Safety and Tolerability of Semaglutide in Healthy Male Japanese and Caucasian Subjects
RandomizedParallel-groupDouble-blindTreatment
Summary
This trial is conducted in Asia. The aim of the trial is to investigate the pharmacokinetics (the exposure of the trial drug in the body), pharmacodynamics (the effect of the investigated drug on the body), and the safety and tolerability of semaglutide in healthy male Japanese and Caucasian subjects.
Timeline
- Start
- 2014-05-21
- Primary completion
- 2014-10-20
- Completion
- 2014-10-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Semaglutide | Peptide | 0.5 mg | Subcutaneous |
| Subject | Semaglutide | Peptide | 1 mg | Subcutaneous |